Companies
Boston Scientific
S&P 500Health Care· USA

BSX

Challenger

Boston Scientific

$63.18

+2.32%

Open $61.50·Prev $61.75

as of 13 Apr

CHALLENGER

Power Core

The moat in one sentence: Boston Scientific's competitive advantage is procedural workflow density, the accumulation of multiple product lines within the same hospital suite that creates switching costs through operational integration rather than through any single product's clinical superiority.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Multi-Vector Growth Driven by PFA and LAAC Expansion

ROC 200

-38.1%

Referenced in 10 other analyses

Financials

Loading...

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
BSX — Boston Scientific — Power Mapping Analysis — L17X — L17X